Participants
Contact
The Italian blog devoted to science news OggiScienza, like other national and international media, has echoed the research headed by Ernest Giralt and Pau Gorostiza in a collaboration between IRB Barcelona and IBEC.
Published in Angewandte Chemie, the study describes how the researchers have designed peptides that can be regulated by light to control biological processes. This breakthrough in chemical nanobioengineering will allow the development of drugs that can be regulated by light. More information in the press release.
Read the article in OggiScienza (link, PDF in Italian)
Read the news in other media too:
Regió 7 (PDF in Catalan)
ABC (PDF in Spanish)
SINC Agency (PDF in Spanish)
Science Daily (PDF in English)
Pysnnoticias (PDF in Spanish)
Noticias de Guipuzkoa (PDF in Spanish)
Noticias de Navarra (PDF in Spanish)
Le Scienze (PDF in Italian)
EuropaPress (PDF in Spanish)
Eureka Alert (PDF in English)
Diario Siglo XXI (PDF in Spanish)
Agenzia Giornalistica Italia (PDF in Italian)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
